Verrica Pharmaceuticals VRCA 深 滬
交易中 09-20 11:38:13 美东时间
1.84
-0.100
-5.15%
華盛通- 最 高1.95
- 今 開1.95
- 成交量 9.84万股
- 最 低 1.82
- 昨 收 1.94
- 總市值 7739.89万
- 52周最高 11.41
- 市盈率 靜 --
- 換手率 0.23%
- 52周最低 1.77
- 委 比 -87.50%
- 總股本 4206.46万
- 歷史最高 23.29
- 量 比 0.75
- 振 幅 6.70%
- 歷史最低 1.77
- 每 手 1
- 風險率 1.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Verrica Pharmaceuticals Finalizes Agreements with Former Officer
Verrica Pharmaceuticals ( ($VRCA) ) has issued an announcement. Verrica Pharmac...
09-07 22:46
Verrica Pharmaceuticals CCO Joe Bonaccorso Resigns, Assumes Consulting Role
Verrica Pharmaceuticals (VRCA) has provided an announcement. Joe Bonaccorso has...
08-28 05:17
Top 3 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to b...
08-27 20:54
Verrica Pharmaceuticals Analyst Ratings
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-15 17:28
快讯 | Verrica制药公司：Needham将目标价从16美元降低至12美元
Verrica Pharmaceuticals Inc : Needham Cuts Target Price to $12 From $16
08-15 13:10
AstraZeneca's $578M Vaccine Plant In Doubt As UK Government Cuts Funding
AstraZeneca is raising concerns that a manufacturing site could be relocated to France, putting an investment in jeopardy.
08-14 23:04
Why Is Dermatology-Focused Verrica Pharmaceuticals Stock Trading Lower On Wednesday?
Verrica Pharmaceuticals shares positive preliminary results from Part 2 of its Phase 2 trial for VP-315 in treating basal cell carcinoma, showing promising tumor reduction and safety. No serious adverse events reported.
08-14 21:52
Verrica Pharma gains after mid-stage data for cancer therapy
Verrica Pharmaceuticals (NASDAQ:VRCA) added ~11% premarket Tuesday after the dermatology-focused drugmaker announced topline results from a mid-stage trial for its experimental therapy VP-315 targeted...
08-14 21:05
快讯 | verrica制药股价在公布中期肤癌治疗研究初步数据和Q2财报后盘前上涨13.9%
Verrica Pharmaceuticals Shares up 13.9% Premarket After Co Reports Prelim Mid-S...
08-14 20:27
Verrica Pharmaceuticals Unveils Updated Corporate Strategy
Verrica Pharmaceuticals (VRCA) just unveiled an announcement. On August 14, 202...
08-14 20:20
